Erlotinib: A Pharmacoeconomic Review of its Use in Advanced Non-Small Cell Lung Cancer

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.28, Iss.1, 2010-01, pp. : 75-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paclitaxel: A Pharmacoeconomic Review of its Use in Non-Small Cell Lung Cancer

By Plosker G.L. Hurst M.

PharmacoEconomics, Vol. 19, Iss. 11, 2001-11 ,pp. : 1111-1134

Adis International

Access to resources Recommend Favorite

Vinorelbine in Advanced Non-Small Cell Lung Cancer: A Pharmacoeconomic Review

By Coukell A.J. Noble S. Faulds D.

PharmacoEconomics, Vol. 15, Iss. 4, 1999-04 ,pp. : 405-417

Adis International

Access to resources Recommend Favorite

Erlotinib in non-small cell lung cancer: a review

By Blackhall Fiona H Rehman Shazza Thatcher Nicholas

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 6, 2005-06 ,pp. : 995-1002

Informa Healthcare

Access to resources Recommend Favorite

Pemetrexed: A Review of its Use in the Management of Advanced Non-Squamous Non-Small Cell Lung Cancer

By Baldwin Claudine M. Perry Caroline M.

Drugs, Vol. 69, Iss. 16, 2009-11 ,pp. : 2279-2302

Adis International

Access to resources Recommend Favorite

Vinorelbine: A Review of its Use in Elderly Patients with Advanced Non-Small Cell Lung Cancer

By Curran M.P. Plosker G.L.

Drugs & Aging, Vol. 19, Iss. 9, 2002-01 ,pp. : 695-721

Adis International

Access to resources Recommend Favorite